Huntingtin (HTT)
Assets acting on this target.
- Class
- Allele-selective mutant HTT-lowering oligonucleotide
By indication
Related mechanisms
Huntingtin (HTT) drugs compared
3 drugs, stage by indication
| Drug | Developer | Modality | Furthest stage | Stage by indication |
|---|---|---|---|---|
| Votoplam | Novartis | small molecule | Phase 3 | Phase 3 in Huntington's Disease |
| WVE-003 | Wave Life Sciences | oligonucleotide | Phase 1/2 | Phase 1/2 in Huntington's Disease |
| Brezosiran | Regeneron Pharmaceuticals | RNAi (siRNA) | Phase 1 | Phase 1 in Huntington's Disease |